首页|线粒体分裂抑制剂Mdivi-1对星形胶质细胞NLRP3炎症小体及A1活化的影响

线粒体分裂抑制剂Mdivi-1对星形胶质细胞NLRP3炎症小体及A1活化的影响

扫码查看
目的 观察线粒体分裂抑制剂1(Mdivi-1)对星形胶质细胞A1型活化及其相关信号分子的影响.方法 根据CCK-8法筛选浓度,将CTX-TNA2星形胶质细胞分为对照组、ACM组、Mdivi-1低、中、高剂量组.ACM为含预设浓度IL-1α、TNF-α及补体C1q的DMEM高糖培养基.ACM组以ACM刺激24 h,诱导A1型活化.Mdivi-1组分别以相应浓度Mdivi-1预处理2 h,而后以ACM刺激24 h.采用实时荧光定量PCR及免疫印迹检测各组细胞A1型活化相关指标IL-1β、C3及iNOSmRNA水平与蛋白表达;联合免疫荧光及免疫印迹测定各组细胞NLRP3、caspase-1、凋亡相关斑点样蛋白ASC等信号分子表达;以二氢乙锭染色流式细胞分析检测各组干预后细胞ROS水平.结果 CCK-8结果示,5、10、25 μmol·L-1 为 Mdivi-1 干预 CTX-TNA2 细胞的适宜浓度.实时荧光定量PCR及免疫印迹结果表明,与对照组比较,ACM组IL-1 β、C3及iNOS mRNA水平与蛋白表达均明显升高,差异有统计学意义(P<0.05);与ACM组比较,10、25μmol·L-1 Mdivi-1组上述指标基因及蛋白表达水平均有所降低,差异有统计学意义(P<0.05).免疫荧光及免疫印迹结果均证实,ACM刺激下,星形胶质细胞NLRP3炎症小体明显激活;而Mdivi-1干预则能有效逆转ACM刺激下NL-RP3、caspase-1、ASC等表达的升高.DHE染色结果表明,5、10、25 μmol·L-1 Mdivi-1干预均能一定程度上逆转ACM刺激下细胞ROS水平的升高,且该效应与药物剂量呈正相关.结论 线粒体分裂抑制剂Mdivi-1可有效抑制星形胶质细胞A1型活化,该效应可能与其对ROS及NLRP3炎症小体的调节作用相关.
Effects of Mdivi-1,a mitochondrial division inhibitor,on NLRP3 inflammasome and astrocyte type A1 activation
Aim To investigate the effects of Mdivi-1 on A1 astrocyte activation and its associated signaling molecules.Methods CTX-TNA2 astrocytes were di-vided into the control,ACM,and low-,medium-,and high-dose Mdivi-1 groups based on concentration screening via CCK-8 assay.ACM,a DMEM high-glu-cose medium containing preset concentrations of IL-1α,TNF-α,and C1q,was used to induce A1 activa-tion.The ACM group was stimulated with ACM for 24 hours.Mdivi-1 groups were pretreated with correspond-ing concentrations of Mdivi-1 for 2 hours,followed by ACM stimulation for 24 hours.Real-time quantitative PCR and Western blot were employed to assess mRNA levels and protein expression of IL-1β,C3,and iNOS in all groups.Immunofluorescence and Western blot were used to detect the expression of signaling molecules NLRP3,caspase-1,and ASC.DHE labeling was used to assess and flow cytometry was used to examine reac-tive oxygen species(ROS)levels.Results The CCK-8 assay identified 5,10,and 25 μmol·L-1as ap-propriate concentrations for Mdivi-1 intervention in CTX-TNA2 cells.Real-time quantitative PCR and Western blot results indicated that,compared to the control group,IL-1 β,C3,and iNOS mRNA levels and protein expression were significantly elevated in the ACM group(P<0.05).In contrast,these levels were significantly reduced in the 10 and 25 μmnol·L-1 Mdi-vi-1 groups compared to the ACM group(P<0.05).Immunofluorescence and Western blot results confirmed that ACM stimulation significantly activated the NLRP3 inflammasome in astrocytes,while Mdivi-1 intervention effectively reversed the ACM-induced upregulation of NLRP3,caspase-1,and ASC.DHE staining results demonstrated that 5,10,and 25 μmol·L-1Mdivi-1 in-terventions partially reversed the ACM-induced in-crease in ROS levels in a dose-dependent manner.Conclusion Mdivi-1 effectively inhibits A1 astrocyte activation,potentially through modulation of ROS and the NLRP3 inflammasomes.

mitochondrial fission inhibitorMdivi-1astrocytesA1reactive oxygen speciesNLRP3 in-flammasomes

刘书芬、陈旭青、张亚运、姚敏、周龙云

展开 >

上海中医药大学附属龙华医院,上海 200032

南京中医药大学附属医院,江苏南京 210029

扬州大学附属医院,江苏扬州 225000

南京医科大学第一附属医院,江苏南京 210029

展开 >

线粒体分裂抑制剂 Mdivi-1 星形胶质细胞 A1 活性氧 NLRP3炎症小体

2025

中国药理学通报
中国药理学会

中国药理学通报

北大核心
影响因子:1.54
ISSN:1001-1978
年,卷(期):2025.41(1)